BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 2014

View Archived Issues

Stallergenes and ActoGenix to develop new class of oral allergy treatments

Read More

FUJIFILM Pharma signs an agreement with Merck Serono for Saizen

Read More

Yabao Pharmaceutical and MRC Technology collaborate to discover Parkinson's disease drugs

Read More

In vivo data presented for the selective LSD1 inhibitor GSK-2879552

Read More

Novel gene linked to mitochondrial myopathy

Read More

Protective effect of a vaccine against cutaneous leishmaniasis in a canine model

Read More

Merck KGaA patents new GCN2 inhibitors

Read More

U.S. investigators disclose new class II FBA inhibitors

Read More

Rociletinib shows good tolerability and durable activity in the phase I/II TIGER-X study

Read More

CRT teams up with Cancer Research UK Manchester to develop lung cancer drugs

Read More

Intra-Cellular Therapies reports additional data from phase I/II trial of ITI-007

Read More

PRO-028 and PRO-027: novel NAC analogues for cocaine addiction

Read More

Modified human cardiac stem cells overexpressing SDF-1-alpha enhance cardiac repair

Read More

Novel TGF-beta inhibitors disclosed by U.S. institutions

Read More

Brown University divulges novel selective bacterial proteasome inhibitors

Read More

Nimbus Apollo discloses new ACC2 inhibitors

Read More

University of Florida presents novel peptidomimetic antimicrobials

Read More

Santen launches TAPCOM solution for glaucoma and ocular hypertension

Read More

FDA approves Onexton gel for the treatment of acne vulgaris

Read More

ATX-F8-117 receives European orphan medicinal product designation for hemophilia A

Read More

First-in-human study of OBT-357 begins in acute myeloid leukemia

Read More

Soliris receives orphan drug designation in Japan for neuromyelitis optica

Read More

Ipsen and collaborators establish Archi-Pex joint research and innovation lab

Read More

Ocata granted European ATMP designation for RPE program for macular degeneration

Read More

Calzada to divest interest in Metabolic Pharmaceuticals

Read More

BioMarin Pharmaceutical to acquire Prosensa

Read More

Corporate name changes for Bioniche Life Sciences and Aastrom Biosciences

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2026.
  • Liver disease

    FB-7033 demonstrates efficacy in MASH management

    BioWorld Science
    17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
  • Illustration of antibody carrying radioactive isotope

    Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC

    BioWorld Science
    At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
  • Bial-Portela discovers new OX1 receptor antagonists

    BioWorld Science
    Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
  • New York University identifies new analogues of mannose-6-phosphate

    BioWorld Science
    New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing